ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Cellectis (CLLS) Says Two Issued US Patents Granted for CRISPR Use in T-Cells – StreetInsider.com

Continue reading

2018-02-13 Michael Zand NEWS

A synthetic cell that produces anti-cancer drugs within a tumor – Phys.Org

Phys.OrgA synthetic cell that produces anti-cancer drugs within a tumorPhys.OrgThe researchers integrated molecular machines within lipid-based particles resembling the natural membrane of biological cells. They engineered the particles such that when … Continue reading

2018-02-13 Michael Zand NEWS

Gene therapy could hold key to improving Aids treatment and beating devastating virus – The Independent

The IndependentGene therapy could hold key to improving Aids treatment and beating devastating virusThe IndependentThe hope is that the medicines plus the altered cells will knock down the virus and reduce the reservoir to a point where the body can co… Continue reading

2018-02-13 Michael Zand NEWS

Gene therapy could hold key to beating Aids virus – The Independent

Gene therapy could hold key to beating Aids virusThe IndependentOnly a few of the 100 others in those experiments were able to stay off HIV drugs for a couple years; the rest still need medicines to keep HIV suppressed. Now researchers think they can i… Continue reading

2018-02-13 Michael Zand NEWS

DowDuPont revealed as the surprise leader in global CRISPR patents; study points to potential trouble ahead – IAM (blog)


Channel NewsAsia

Cellectis (CLLS) Says Two Issued US Patents Granted for CRISPR Use in T-Cells
StreetInsider.com
Cellectis (NASDAQ: CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), announced today the issuance of two U.S. patents – US 9,855,297 and US 9,890,393 – for the …
France’s Cellectis wins US patents for gene editing technologyETHealthworld.com

all 3 news articles »

Continue reading

2018-02-13 Michael Zand NEWS

DowDuPont revealed as the surprise leader in global CRISPR patents; study points to potential trouble ahead – IAM (blog)

DowDuPont revealed as the surprise leader in global CRISPR patents; study points to potential trouble ahead
IAM (blog)
A new study of the global CRISPR patent landscape released today provides the most detailed insight yet into how entities are seeking to protect their inventions relating to the revolutionary technology. Speaking exclusively to IAM, the report’s author …

and more »

Continue reading

2018-02-13 Michael Zand NEWS

3D culture system enables stem cell expansion – Medical Physics Web

3D culture system enables stem cell expansionMedical Physics WebHuman pluripotent stem cells are cells that can be grown into multiple different types. The differentiation of these stem cells provides a variety of human cell types for use in tissue mod… Continue reading

2018-02-13 Michael Zand NEWS

3D culture system enables stem cell expansion – Medical Physics Web

3D culture system enables stem cell expansionMedical Physics WebHuman pluripotent stem cells are cells that can be grown into multiple different types. The differentiation of these stem cells provides a variety of human cell types for use in tissue mod… Continue reading

2018-02-13 Michael Zand NEWS
  • 1
  • …
  • 539
  • 540
  • 541
  • 542
  • 543
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

DowDuPont revealed as the surprise leader in global CRISPR patents; study points to potential trouble ahead
IAM (blog)
A new study of the global CRISPR patent landscape released today provides the most detailed insight yet into how entities are seeking to protect their inventions relating to the revolutionary technology. Speaking exclusively to IAM, the report’s author …

and more »